Hematology/Oncology

Top Story

Extended adjuvant letrozole improves DFS among certain postmenopausal women with breast cancer

Extended adjuvant letrozole improves DFS among certain postmenopausal women with breast cancer
December 13, 2019
Meeting NewsVideo

VIDEO: ASH recognizes research on molecular mechanisms of blood coagulation

December 12, 2019
ORLANDO — In this video at the ASH Annual Meeting and Exposition, Sriram M. Krishnaswamy, PhD, of the University of Pennsylvania and Children’s Hospital of…
Meeting News

Doptelet cost-effective, avoids transfusions for CLD-related thrombocytopenia

December 12, 2019
Treatment with Doptelet was cost-effective for the treatment of thrombocytopenia in patients with chronic liver diseases compared with other treatment options, according…
Drug Pipeline

Kite submits BLA to FDA for CAR T-cell therapy in mantle cell lymphoma

December 12, 2019
Biopharma company Kite, a subsidiary of Gilead, has submitted a biologics license application to the FDA for the company’s investigational chimeric antigen…
In the Journals

Associations urge caution after controversial radioactive iodine findings

December 12, 2019
The Society for Endocrinology and the British Thyroid Association issued a joint statement urging caution when interpreting a recent study linking radioactive iodine…
More Headlines »
CME

Innovations in Sickle Cell Disease: How the Latest Advances May Impact Clinical Decision-making

This activity is supported by an educational grant from Global Blood Therapeutics.

Sickle cell disease (SCD) is an inherited molecular condition whose clinical severity has extreme phenotypic…
More »
Video
Meeting News

VIDEO: ASH recognizes research on molecular mechanisms of blood coagulation

December 12, 2019
More »
Resource Centers
European Society for Medical Oncology Congress

European Society for Medical Oncology Congress

CME

Clinical Advances in Hepatocellular Carcinoma Management – Rapid Response from Chicago

This activity is supported by an educational grant from Merck & Co., Inc.

Hepatocellular carcinoma (HCC) is an aggressive tumor that is commonly diagnosed late in the course of the disease…
More »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next